- $1.16bn
- $1.44bn
- $568.09m
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Bioventus rises after better-than-expected quarterly results
Bioventus beats Q4 revenue estimates on strong demand for pain treatments and surgical solutions
Bioventus Q3 revenue beats expectations, EPS up 200%
Bioventus Inc reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue dips 2.4%, organic growth 6.2%
Bioventus Inc expected to post earnings of 21 cents a share - Earnings Preview
Brief: Bioventus Enters Into A New $400 Million Senior Secured Credit Agreement
Brief: Bioventus Inc - Plans Limited Release Of Talismann And Stimtrial In Some U.S. Markets In Q3
Bioventus Inc reports results for the quarter ended March 31 - Earnings Summary
Bioventus Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Bioventus jumps after upbeat Q4 results
Bioventus Inc reports results for the quarter ended December 31 - Earnings Summary